ECONVY Trademark

Trademark Overview


On Tuesday, March 17, 2020, a trademark application was filed for ECONVY with the United States Patent and Trademark Office. The USPTO has given the ECONVY trademark a serial number of 88837151. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, April 24, 2023. This trademark is owned by 3D Medicines (Sichuan) Co., Ltd.. The ECONVY trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for the prevention and treatment of tumors; Pharmaceutical preparations and substances for the treatment of viral related diseases and disorders; Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; Pharmaceutical preparations and substances for the treatment of immune system related diseases and disorders; Antiviral drugs for medical purposes; Drugs for medical purposes for the treatment of tumors; Crude drugs for the treatment of immune system related diseases and disorders; Crude drugs for the treatment of cancer; Medicated lozenges; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Injectable pharmaceuticals for treatment of cancer; Implantable subcuta...
econvy

General Information


Serial Number88837151
Word MarkECONVY
Filing DateTuesday, March 17, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, April 24, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 21, 2020

Trademark Statements


Description of MarkThe mark consists of the word "ECONVY" in stylized font.
Goods and ServicesMedicinal preparations for the prevention and treatment of tumors; Pharmaceutical preparations and substances for the treatment of viral related diseases and disorders; Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; Pharmaceutical preparations and substances for the treatment of immune system related diseases and disorders; Antiviral drugs for medical purposes; Drugs for medical purposes for the treatment of tumors; Crude drugs for the treatment of immune system related diseases and disorders; Crude drugs for the treatment of cancer; Medicated lozenges; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Injectable pharmaceuticals for treatment of cancer; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for the treatment of chronic inflammatory diseases, tumors, infectious diseases, and viral diseases; Anti-cancer preparations; Pharmaceutical products for the prevention and treatment of cancer; Biological preparations for the treatment of cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 21, 2020
Primary Code005
First Use Anywhere DateWednesday, September 1, 2021
First Use In Commerce DateWednesday, September 1, 2021

Trademark Owner History


Party Name3D Medicines (Sichuan) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressChengdu Sichuan
CN

Party Name3D Medicines (Sichuan) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressChengdu Sichuan
CN

Trademark Events


Event DateEvent Description
Monday, April 24, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, April 24, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, April 24, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, October 4, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, October 4, 2022FINAL REFUSAL E-MAILED
Tuesday, October 4, 2022SU - FINAL REFUSAL - WRITTEN
Monday, October 3, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 3, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 3, 2022ASSIGNED TO LIE
Tuesday, August 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 22, 2022NON-FINAL ACTION E-MAILED
Tuesday, March 22, 2022SU - NON-FINAL ACTION - WRITTEN
Tuesday, March 22, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, March 14, 2022USE AMENDMENT FILED
Tuesday, March 22, 2022SOU EXTENSION 3 GRANTED
Monday, March 14, 2022SOU EXTENSION 3 FILED
Tuesday, March 22, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 14, 2022TEAS EXTENSION RECEIVED
Monday, March 14, 2022TEAS STATEMENT OF USE RECEIVED
Thursday, September 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 7, 2021SOU EXTENSION 2 GRANTED
Tuesday, September 7, 2021SOU EXTENSION 2 FILED
Tuesday, September 7, 2021TEAS EXTENSION RECEIVED
Wednesday, March 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 15, 2021SOU EXTENSION 1 GRANTED
Monday, March 15, 2021SOU EXTENSION 1 FILED
Monday, March 15, 2021TEAS EXTENSION RECEIVED
Tuesday, September 15, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 9, 2020ASSIGNED TO EXAMINER
Saturday, March 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 20, 2020NEW APPLICATION ENTERED